Treatment of patients with asthma with a fixed combination of budesonide and formoterol: A pharmacoeconomic evaluation vs some therapeutic alternatives

PharmacoEconomics - Italian Research Articles

Volumn 4, Issue 1, 2002, Pages 15-23

  Lucioni, Carlo ^a   Mangrella, M ^b   Mazzi, S ^a   Negrini, C ^b   Vaghi, A ^c  

^a Istituto di Economia Sanitaria   (Italy)

^b ASTRAZENECA   (United Kingdom)

^c Ospedale di Garbagnate   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; FLUTICASONE PROPIONATE; FORMOTEROL; TERBUTALINE;

ARTICLE; ASTHMA; CLINICAL STUDY; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG CHOICE; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; INHALER; ITALY;

EID: 0036259374     PISSN: 15909158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03320590     Document Type: Article

References (29)

1. National trends in the morbidity and mortality of asthma in the US: Prevalence, hospitalization and death from asthma over two decades 1965-1984
2. Prevalence of asthma and asthma symptoms in a general population sample of north Italy
3. Prevalence rates of diagnosis of asthma in general population samples of Northern and Central Italy
4. Prevalence of asthma and asthma symptoms in a general population sample from Northern Italy
5. Studi di cost-of-illness dell'asma: Una review della letteratura internazionale 1990-1995
6. I1 costo dell'asma in Italia
7. I1 costo sociale dell'asma nell'adulto, in Italia
8. Effect of inhaled formoterol and budesonide on exacerbations of asthma
9. Global Initiative for Asthma. Pocket guide for asthma management
10. What is new since the last (1999) Canadian Asthma Consensus Guidelines?
11. Health economics evaluation of budesonide/formoterol in one inhaler compared to the same substances, in corresponding dosages, in two separate inhalers
12. Healthcare costs are reduced when asthma is treated with budesonide and formoterol in a single inhaler compared with the same medication via separate inhalers
13. The valuation of human capital
14. Estimating costs in cost-effectiveness analysis
15. Productivity costs measurement through quality of life? A response to the recommendation of the Washington panel
16. Relazione generale sulla situazione economica del Paese
17. I tempi e i costi di lavoro associati al trattamento farmacologico: Analisi di alcune opportunità di risparmio
18. Productivity costs, time costs and health-related quality of life: A response to the Erasmus Group
19. Symbicort®, (budesonide and formoterol in a single inhaler) is a more effective treatment than fluticasone in asthma patients
20. Lower healthcare costs with Symbicort® Turbuhaler® in the treatment of asthma
21. DRG: Strategic, valutazione, monitoraggio
22. Productivity costs: Principles and practice in economic evaluation